The global intellectual property landscape of induced pluripotent stem cell technologies

Will freedom to research and innovate be restricted as the induced pluripotent stem cell field advances toward the clinic, or are concerns premature within a rapidly changing ecosystem?

Saved in:
Bibliographic Details
Published inNature biotechnology Vol. 32; no. 8; pp. 742 - 748
Main Authors Roberts, MacKenna, Wall, Ivan B, Bingham, Ian, Icely, Dominic, Reeve, Brock, Bure, Kim, French, Anna, Brindley, David A
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.08.2014
Nature Publishing Group
Subjects
631/532/2064/2158
631/61/490
706/648/270
706/703/270
Agriculture
Bioinformatics
Biomedical Engineering/Biotechnology
Biomedicine
Biotechnology
Drug therapy
Induced Pluripotent Stem Cells
Intellectual Property
Internationality
Life Sciences
Patents as Topic
Patients
Stem cells
Online AccessGet full text

Cover

More Information
Summary:Will freedom to research and innovate be restricted as the induced pluripotent stem cell field advances toward the clinic, or are concerns premature within a rapidly changing ecosystem?
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1087-0156
1546-1696
DOI:10.1038/nbt.2975